Manufacturing

EMA issues Q&A guideline on additive manufacturing

EMA has published a new Q&A guideline focused on GMP and quality aspects related to 3D printing in pharmaceutical manufacturing. The document applies to human and veterinary medicines as well as investigational products

IFPMA’s position on AI in pharmaceutical manufacturing

Artificial Intelligence (AI) and Machine Learning (ML) are playing an increasingly central role in pharmaceutical manufacturing and control. A position paper published by IFPMA in March 2026 outlines both the opportunities and the challenges associated with their adoption across the sector

R&D

EMA Horizon Scanning: microgravity

EMA Horizon Scanning: new reports explore targeted protein degradation and microgravity

Two emerging areas have been highlighted through EMA’s Horizon Scanning activities. Targeted protein degradation (TPD) seeks to remove disease-associated proteins by exploiting the cell’s own degradation pathways, while research, development and manufacturing in microgravity could open the way to medicinal products with improved properties

More than €830 million awarded through ERC Advanced Grants 2025

The European Research Council has announced the results of the 2025 Advanced Grants competition, allocating a total of €838 million to support frontier research projects led by established scientists across Europe.The grants are designed to enable ambitious, high-risk, high-gain research that could lead to major scientific breakthroughs

Newsstand

  • NCF International n.1 - 2026 NCF International n.1 - 2026
  • NCF International n.2 - 2025 NCF International n.2 - 2025
  • NCF International n.1 - 2025 NCF International n.1 - 2025